TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue …
Read More